arrow
A

Aly Karsan

british columbia cancer agency
H指数:64
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Initial leukemic epigenomic state determines hypomethylating agent response

初始白血病表观基因组状态决定去甲基化药物的反应

2026-05-010
PRE
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma

LySeqST:一种用于弥漫性大B细胞淋巴瘤稳健基因组分类的靶向测序检测方法

2026-04-170
OAAI
Loss of FBXO11 establishes a stem cell program in acute myeloid leukemia by dysregulating LONP1

FBXO11的缺失通过失调LONP1在急性髓系白血病中建立干细胞程序

2026-01-160
OA
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

携带有害的胚系CHEK2变异导致的血液系统恶性肿瘤易感性

LEUKEMIA
IF13.4
2025-05-070
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

真实世界回顾性队列中接受强化化疗的伴有骨髓增生异常相关改变(AML-MRC)的急性髓系白血病患者的生存结局

BLOOD
IF23.1
2024-11-050
PRE
Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis (vol 15, 2340, 2024)
2024-10-070
OAAI
Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis
2024-03-153
OAAI
I just wanted more: Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screening
2023-10-111
OA